Lexeo Therapeutics (LXEO) Current Leases (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Current Leases of $528000.0 for Q1 2026, down 75.52% sequentially from $2.2 million in Q4 2025, and down 75.16% YoY from $2.1 million in Q1 2025.
Lexeo Therapeutics (LXEO) Current Leases (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has reported Current Leases for 5 years, with the latest figure at $528000.0 in Q1 2026.
- Quarterly Current Leases fell 75.16% year-over-year to $528000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $528000.0 (down 75.16% YoY) and the FY2025 annual result came in at $2.2 million, up 2.71% from the prior year.
- Current Leases slipped to $528000.0 in Q1 2026 per LXEO's latest filing, from $2.2 million in the prior quarter.
- Over five years, Current Leases peaked at $2.3 million in Q4 2022 and troughed at $518000.0 in Q4 2023.
- A 5-year average of $1.1 million and a median of $570000.0 in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases slumped 77.35% in 2023, then jumped 305.73% in 2025.
- Over 5 years, Current Leases stood at $2.3 million in 2022, then plunged by 77.35% to $518000.0 in 2023, then soared by 305.41% to $2.1 million in 2024, then advanced by 2.71% to $2.2 million in 2025, then slumped by 75.52% to $528000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $528000.0, $2.2 million, and $568000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Lexeo Therapeutics | 397.10 Mn | 397.10 Mn | - | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.18 Mn |
| Mar 31, 2026 | 528,000.00 |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | 568,000.00 |
| Jun 30, 2025 | 520,000.00 |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 574,000.00 |
| Jun 30, 2024 | 572,000.00 |
| Mar 31, 2024 | 524,000.00 |
| Dec 31, 2023 | 518,000.00 |
| Sep 30, 2023 | 519,000.00 |
| Dec 31, 2022 | 2.29 Mn |